Martin Wilhelm

Prof. Ernst Nathan Str. 1
Nuernberg, BY 90419, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Characterization of Stimulated γδ T Cells: Phenotypic Analysis and Implications for Allogeneic Cellular Immunotherapy.

Characterization of Stimulated γδ T Cells: Phenotypic Analysis and Implications for Allogeneic Cellular Immunotherapy.

Journal: Cells

Published: September 19, 2025

An optimized cultivation method for future in vivo application of γδ T cells.

An optimized cultivation method for future in vivo application of γδ T cells.

Journal: Frontiers in immunology

Published: March 13, 2023

Haploidentical γδ T Cells Induce Complete Remission in Chemorefractory B-cell Non-Hodgkin Lymphoma.

Haploidentical γδ T Cells Induce Complete Remission in Chemorefractory B-cell Non-Hodgkin Lymphoma.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: June 20, 2022

Immune activating and inhibiting effects of calcitriol on γδ T cells and NK cells.

Immune activating and inhibiting effects of calcitriol on γδ T cells and NK cells.

Journal: Immunobiology

Published: June 03, 2022

Specialized Biopsychosocial Care in Inpatient Somatic Medicine Units-A Pilot Study.

Specialized Biopsychosocial Care in Inpatient Somatic Medicine Units-A Pilot Study.

Journal: Frontiers in public health

Published: December 28, 2021

Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapy.

Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapy.

Journal: Cancer immunology, immunotherapy : CII

Published: June 30, 2021

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.

Journal: Blood

Published: August 31, 2020

Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper.

Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper.

Journal: Oncology research and treatment

Published: July 11, 2020

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.

Journal: The Lancet. Oncology

Published: May 28, 2020

Relationship between prior antibiotic treatment and response to immune checkpoint inhibitor therapy and survival in patients with cancer

Relationship between prior antibiotic treatment and response to immune checkpoint inhibitor therapy and survival in patients with cancer

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Published: March 14, 2020

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.

Journal: Leukemia

Published: December 14, 2019

Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials.

Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials.

Journal: The oncologist

Published: October 13, 2019

Showing 1-12 of 46

Last Updated: 09/26/2026